New insights into ADPKD molecular pathways using combination of SAGE and microarray technologies

Area of Science:

• Genetics
• Molecular Biology
• Nephrology

Background:

• Autosomal dominant polycystic kidney disease (ADPKD) is a genetic disorder characterized by cyst formation in the kidneys and liver.
• The precise cellular mechanisms driving ADPKD cystogenesis are not fully understood.
• Mutations in PKD1 or PKD2 genes are the primary cause of ADPKD.

Purpose of the Study:

• To identify cyst-specific molecules and elucidate the disease pathway in ADPKD.
• To comprehensively analyze gene expression profiles in normal versus ADPKD epithelia.
• To discover potential therapeutic targets for ADPKD.

Main Methods:

• Utilized serial analysis of gene expression (SAGE) to profile gene expression in normal and ADPKD kidney and liver epithelia.
• Developed a custom cDNA microarray based on SAGE-identified differentially expressed genes.
• Interrogated ADPKD patient samples using the custom microarray for further gene expression analysis.

Main Results:

• Identified 472 and 499 differentially expressed genes in liver and kidney ADPKD epithelia, respectively, with a fivefold difference.
• Genes identified are involved in growth factors, transcription, proteolysis, apoptosis, cell-matrix interactions, and ion channels.
• Refined the gene set to 26 up-regulated and 48 down-regulated genes (p<0.01) in ADPKD patients.

Conclusions:

• The study provides significant insights into the molecular pathophysiology of ADPKD.
• The identified differentially expressed genes represent potential targets for future ADPKD therapies.
• This research advances the understanding of cystogenesis in ADPKD.